Woodline Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $8.66M | Sell |
|
|||||
|
2025
Q1 | $14.7M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.93M | Sell |
|
|||||
|
2024
Q1 | $17M | Buy |
|
|||||
|
2023
Q4 | $13.3M | Sell |
|
|||||
|
2023
Q3 | $34.1M | Sell |
|
|||||
|
2023
Q2 | $109M | Buy |
|
|||||
|
2023
Q1 | $40.4M | Buy |
|
|||||
|
2022
Q4 | $36.8M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $24.3M | Buy |
|
|||||
|
2021
Q4 | $10.9M | Sell |
|
|||||
|
2021
Q3 | $60.4M | Buy |
|
|||||
|
2021
Q2 | $37.5M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $7.68M | Buy |
|